• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观遗传 DNA 修饰与维生素 C 在前列腺癌和良性前列腺增生中的作用:探索相似性、差异性及其致病意义。

Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications.

机构信息

Department of Clinical Biochemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz 85-092, Poland.

Department of Urology, Jan Biziel University Hospital, Bydgoszcz 85-168; Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Poland.

出版信息

Neoplasia. 2024 Dec;58:101079. doi: 10.1016/j.neo.2024.101079. Epub 2024 Oct 29.

DOI:10.1016/j.neo.2024.101079
PMID:39471555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11550371/
Abstract

OBJECTIVES

Benign Prostatic Hyperplasia (BPH) and Prostate Cancer (PC) are very common pathologies among aging men. Both disorders involve aberrant cell division and differentiation within the prostate gland. However, the direct link between these two disorders still remains controversial. A plethora of works have demonstrated that inflammation is a major causative factor in both pathologies. Another key factor involved in PC development is DNA methylation and hydroxymethylation.

METHODS

A broad spectrum of parameters, including epigenetic DNA modifications and 8-oxo-7,8-dihydro-2'-deoxyguanosine, was analyzed by two-dimensional ultraperformance liquid chromatography with tandem mass spectrometry in tissues of BPH, PC, and marginal one, as well as in leukocytes of the patients and the control group. In the same material, the expression of TETs and TDG genes was measured using RT-qPCR. Additionally, vitamin C was quantified in the blood plasma and within cells (leukocytes and prostate tissues).

RESULTS

Unique patterns of DNA modifications and intracellular vitamin C (iVC) in BPH and PC tissues, as well as in leukocytes, were found in comparison with control samples. The majority of the alterations were more pronounced in leukocytes than in the prostate tissues.

CONCLUSIONS

Characteristic DNA methylation/hydroxymethylation and iVC profiles have been observed in both PC and BPH, suggesting potential shared molecular pathways between the two conditions. As a fraction of leukocytes may be recruited to the pathological tissues and can migrate back into the circulation/blood, the observed alterations in leukocytes may reflect dynamic changes associated with the PC development, suggesting their potential utility as early markers of prostate cancer development.

摘要

目的

良性前列腺增生症(BPH)和前列腺癌(PC)是老年男性中非常常见的疾病。这两种疾病都涉及前列腺内异常的细胞分裂和分化。然而,这两种疾病之间的直接联系仍然存在争议。大量研究表明,炎症是这两种疾病的主要致病因素。另一个与 PC 发展相关的关键因素是 DNA 甲基化和羟甲基化。

方法

通过二维超高效液相色谱-串联质谱法分析了 BPH、PC 和边缘组织以及患者和对照组白细胞中的广泛参数,包括表观遗传 DNA 修饰和 8-氧-7,8-二氢-2'-脱氧鸟苷。在相同的材料中,使用 RT-qPCR 测量了 TETs 和 TDG 基因的表达。此外,还定量了血浆和细胞内(白细胞和前列腺组织)的维生素 C。

结果

与对照样本相比,在 BPH 和 PC 组织以及白细胞中发现了独特的 DNA 修饰和细胞内维生素 C(iVC)模式。大多数改变在白细胞中比在前列腺组织中更为明显。

结论

在 PC 和 BPH 中观察到特征性的甲基化/羟甲基化和 iVC 谱,表明这两种情况之间可能存在共同的分子途径。由于白细胞的一部分可能被募集到病变组织中,并可迁移回循环/血液中,因此白细胞中观察到的改变可能反映与 PC 发展相关的动态变化,提示它们可能作为前列腺癌发展的早期标志物具有潜在的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/7fe4665247e9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/15ad2fa535ab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/bb39294623f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/245f011ebcd6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/4c6f531870c5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/de4043b1ddc9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/7fe4665247e9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/15ad2fa535ab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/bb39294623f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/245f011ebcd6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/4c6f531870c5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/de4043b1ddc9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8008/11550371/7fe4665247e9/gr6.jpg

相似文献

1
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications.表观遗传 DNA 修饰与维生素 C 在前列腺癌和良性前列腺增生中的作用:探索相似性、差异性及其致病意义。
Neoplasia. 2024 Dec;58:101079. doi: 10.1016/j.neo.2024.101079. Epub 2024 Oct 29.
2
Unprecedentedly High Level of Intracellular Vitamin C and DNA Epigenetic Marks in Prostate: Relevant for Male Fertility?前列腺细胞内维生素 C 和 DNA 表观遗传标记水平空前升高:与男性生育力有关吗?
Cell Physiol Biochem. 2023 Jun 19;57(4):200-211. doi: 10.33594/000000638.
3
The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.表观遗传学在前列腺癌和良性前列腺增生的发生、诊断及治疗中的作用不断扩展。
J Urol. 2007 Mar;177(3):822-31. doi: 10.1016/j.juro.2006.10.063.
4
Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.与良性前列腺增生相比,前列腺癌中IGF2/H19基因CTCF结合域的异常表观遗传修饰。
Int J Oncol. 2009 Jul;35(1):87-96. doi: 10.3892/ijo_00000316.
5
Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.前列腺癌中肝癌缺失基因-1的异常甲基化与去乙酰化:潜在的临床应用
Clin Cancer Res. 2006 Mar 1;12(5):1412-9. doi: 10.1158/1078-0432.CCR-05-1906.
6
Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.在印度东部的患者人群中,前列腺癌发生过程中 DNA 表观遗传调节剂失调:预后意义。
Pathol Res Pract. 2024 Jan;253:154970. doi: 10.1016/j.prp.2023.154970. Epub 2023 Nov 23.
7
Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.利用遗传和表观遗传标志物通过非侵入性方法改善墨西哥患者前列腺癌和良性前列腺增生的鉴别诊断。
Clin Genitourin Cancer. 2018 Aug;16(4):e867-e877. doi: 10.1016/j.clgc.2018.02.004. Epub 2018 Feb 27.
8
Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study.在一项探索性研究中,与 PSA 相比,测量白细胞 DNA 整体羟甲基化在前列腺癌中的临床意义。
Int J Mol Sci. 2017 Nov 20;18(11):2465. doi: 10.3390/ijms18112465.
9
Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease.结肠癌及其前期病变(良性腺瘤和炎症性肠病)中 DNA 表观遗传修饰的特征谱。
Clin Epigenetics. 2018 May 30;10:72. doi: 10.1186/s13148-018-0505-0. eCollection 2018.
10
DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate.DNA 甲基化作为发育和疾病过程的动态调节剂:聚焦于前列腺。
Epigenomics. 2015;7(3):413-25. doi: 10.2217/epi.15.8.

引用本文的文献

1
Pioneering contribution of Professor Bruce Ames to early development in biochemical aspects of oxidatively generated damage to DNA.布鲁斯·艾姆斯教授在氧化导致的DNA损伤生化方面早期发展中的开创性贡献。
Front Mol Biosci. 2025 Aug 20;12:1636255. doi: 10.3389/fmolb.2025.1636255. eCollection 2025.

本文引用的文献

1
Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps.基于中性粒细胞胞外诱捕网的前列腺腺癌分子亚型鉴定及预后特征分析
J Cancer. 2024 Mar 17;15(9):2678-2690. doi: 10.7150/jca.93275. eCollection 2024.
2
The level of active DNA demethylation compounds in leukocytes and urine samples as potential epigenetic biomarkers in breast cancer patients.白细胞和尿液样本中活性 DNA 去甲基化化合物作为乳腺癌患者潜在的表观遗传生物标志物的水平。
Sci Rep. 2024 Mar 18;14(1):6481. doi: 10.1038/s41598-024-56326-5.
3
Intracellular ascorbate is a safe-guard and/or reservoir for plasma vitamin C in prostate cancer patients undergoing radiotherapy.
在接受放疗的前列腺癌患者中,细胞内抗坏血酸是血浆维生素 C 的保护者和/或储备库。
Free Radic Biol Med. 2024 Jan;210:230-236. doi: 10.1016/j.freeradbiomed.2023.11.024. Epub 2023 Nov 29.
4
Unprecedentedly High Level of Intracellular Vitamin C and DNA Epigenetic Marks in Prostate: Relevant for Male Fertility?前列腺细胞内维生素 C 和 DNA 表观遗传标记水平空前升高:与男性生育力有关吗?
Cell Physiol Biochem. 2023 Jun 19;57(4):200-211. doi: 10.33594/000000638.
5
SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.SALL4 通过影响 MAPK 通路与前列腺癌的增殖、转移和不良预后相关。
Cancer Med. 2023 Jun;12(12):13471-13485. doi: 10.1002/cam4.5998. Epub 2023 Apr 29.
6
8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification.8-氧鸟嘌呤:从氧化损伤到表观遗传和转录后修饰。
Exp Mol Med. 2022 Oct;54(10):1626-1642. doi: 10.1038/s12276-022-00822-z. Epub 2022 Oct 21.
7
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.前列腺癌中的 5-羟甲基胞嘧啶景观。
Cancer Res. 2022 Nov 2;82(21):3888-3902. doi: 10.1158/0008-5472.CAN-22-1123.
8
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.癌性和非癌性前列腺组织中形态正常组织克隆扩增的结构。
Mol Cancer. 2022 Sep 22;21(1):183. doi: 10.1186/s12943-022-01644-3.
9
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.前列腺癌发生、进展及治疗反应中的染色质与表观遗传失调
Cancers (Basel). 2021 Jul 2;13(13):3325. doi: 10.3390/cancers13133325.
10
Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer.前列腺癌中表观遗传生物标志物和表观遗传靶向治疗的最新进展
Eur Urol. 2021 Jul;80(1):71-81. doi: 10.1016/j.eururo.2021.03.005. Epub 2021 Mar 27.